The data indicated that several hub genes, such as tumor protein p53 (TP53), mammalian target of rapamycin (MTOR) and mitogen-activated protein kinase 1 (MAPK1), were closely linked to the biological processes in YTH domain family in HCC patients (Figure 4C). This evidence concerns the gene MAP2K1 and hepatocellular carcinoma.